Skip to main content

A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea

Abstract

Background

With increasing use of atypical antipsychotic (AAP) agents, the concern has been raised about the association between AAP agents and medical complications. Obstructive sleep apnea (OSA) is a common breathing disorder that adversely affects health and quality of life. Because the major risk factors for OSA are weight gain and obesity by altering the upper airway anatomy, an association between AAP and development of OSA is predictable. However, we hypothesized that AAP may promote OSA not only by weight gain but also because of its potential effects on upper airway muscle function. In the present study, we evaluated the possible association between AAP use and the severity of OSA.

Methods

A sample of patients using AAP for treatment of paradoxical insomnia was evaluated before and at least 8 weeks after AAP use. Patients were divided based on type of AAP use to olanzapine, risperidone, and quetiapine groups. Patients used olanzapine (5–10 mg), risperidone (2–4 mg), or quetiapine (100–200 mg) 2 h before bedtime. Before and after treatment, respiratory variables were recorded using polysomnography. BMI, neck circumference (NC), and waist circumference (WC) were measured before and after treatment period.

Results

There was no significant difference between pre- and post-treatment apnea index (0.2 ± 0.6 vs. 2.6 ± 4.3; p = 0.094) in olanzapine group. However, significant differences in hypopnea index (5.1 ± 5 vs. 30 ± 10.8; p < 0.0001) and AHI (5.3 ± 4.9 vs. 32.6 ± 9.6; p < 0.0001) were observed. Similar results were found in quetiapine and risperidone groups, except that in quetiapine group, apnea index was significantly increased after treatment period (0.7 ± 1.2 in pre-treatment vs. 3.1 ± 2.4 in post-treatment; p = 0.007). There were no significant changes in BMI, NC, and WC during treatment period in all three groups.

Conclusion

While AAP medications are known cause of weight gain as a main risk factor of OSA, our finding demonstrated a weight-independent association between AAP medications and worsening respiration during sleep.

This is a preview of subscription content, access via your institution.

References

  1. Stip E (2002) Happy birthday neuroleptics! 50 years later: la folie du doute. Eur Psychiatry 17(3):115–119

    Article  PubMed  Google Scholar 

  2. Müller DJ, Chowdhury NI, Zai CC (2013) The pharmacogenetics of antipsychotic-induced adverse events. Curr Opin Psychiatry 26(2):144–150

    Article  PubMed  Google Scholar 

  3. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373(9657):31–41

    CAS  Article  PubMed  Google Scholar 

  4. Khazaie H, Najafi F, Rezaie L, Tahmasian M, Sepehry AA, Herth FJ (2011) Prevalence of symptoms and risk of obstructive sleep apnea syndrome in the general population. Arch Iran Med 14(5):335–338

    PubMed  Google Scholar 

  5. Shirani A, Paradiso S, Dyken ME (2011) The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. Sleep Med 12(6):591–597

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sadock BJ, Sadock VA (2009) Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th edn. Lippincott Williams & Wilkins, New York

    Google Scholar 

  7. American Academy of Sleep Medicine (2005) The international classification of sleep disorders: diagnostic and coding manual. American Academy of Sleep Medicine, Westchester, pp 51–55

    Google Scholar 

  8. Hoffstein V (2002) Relationship between smoking and sleep apnea in clinic population. Sleep 25:519–522

    Article  Google Scholar 

  9. Tasali E, Mokhlesi B, Van Cauter E (2008) Obstructive sleep apnea and type 2 diabetes. Chest 133:496–506

    Article  PubMed  Google Scholar 

  10. Rishi MA, Shetty M, Wolff A, Amoateng-Adjepong Y, Manthous CA (2010) Atypical antipsychotic medications are independently associated with severe obstructive sleep apnea. Clin Neuropharmacol 33(3):109–113

    Article  PubMed  Google Scholar 

  11. Wirshing DA, Pierre JM, Wirshing WC (2002) Sleep apnea associated with antipsychotic-induced obesity. J Clin Psychiatry 63:369–370

    Article  PubMed  Google Scholar 

  12. Freudenmann RW, Süssmuth SD, Wolf RC, Stiller P, Schönfeldt-Lecuona C (2008) Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry 41(3):119–121

    CAS  Article  PubMed  Google Scholar 

  13. Khazaie H, Rezaie L, Darvishi F, Najafi F, Avis K (2013) Treatment of paradoxical insomnia with atypical antipsychotic drugs. A comparison of olanzapine andrisperidone. Neurosciences (Riyadh) 18(1):64–69

    Google Scholar 

  14. Edinger JD, Bonnet MH, Bootzin RR et al (2004) Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 27(8):1567–1596

    Article  PubMed  Google Scholar 

  15. Khazaie H, Rezaie L, Tahmasian M, Schwebel DC (2010) Insomnia treatment by olanzapine. Is sleep state misperception a psychotic disorder? Neurosciences (Riyadh) 15:110–112

    Google Scholar 

  16. Casey DE, Haupt DW, Newcomer JW (2004) Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 65:4–18

    Article  PubMed  Google Scholar 

  17. Jin H, Meyer JM, Mudaliar S, Jeste DV (2008) Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res 100:70–85

    Article  PubMed  PubMed Central  Google Scholar 

  18. Newcomer JW (2007) Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68:8–13

    Article  PubMed  Google Scholar 

  19. Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M (2005) Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 28:1405–1411

    Article  PubMed  Google Scholar 

  20. Ong JC, Gress JL, San Pedro-Salcedo MG, Manber R (2009) Frequency and predictors of obstructive sleep apnea among individuals with major depressive disorder and insomnia. J Psychosom Res 67:135–141

    Article  PubMed  PubMed Central  Google Scholar 

  21. Deldin PJ, Phillips LK, Thomas RJ (2006) A preliminary study of sleep-disordered breathing in major depressive disorder. Sleep Med 7:131–139

    Article  PubMed  Google Scholar 

  22. Norton JR, Ward DS, Karan S et al (2006) Differences between midazolam and propofol sedation on upper airway collapsibility using dynamic negative airway pressure. Anesthesiology 104:1155–1164

    CAS  Article  PubMed  Google Scholar 

  23. Owens RL, Eckert DJ, Yeh SY et al (2008) Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literature. Curr Opin Pulm Med 14(6):519–524

    Article  PubMed  PubMed Central  Google Scholar 

  24. Malhoutra A, Pillar G, Fogel RB et al (2002) Pharyngeal pressure and flow effects on genioglossus activation in normal subjects. Am J Respir Crit Care Med 165:71–77

    Article  Google Scholar 

  25. Eastwood PR, Szollosi I, Platt PR et al (2002) Collapsibility of the upper airway during anesthesia with isoflurane. Anesthesiology 97:786–793

    CAS  Article  PubMed  Google Scholar 

  26. Mutoh T, Kanamaru A, Kojima K et al (1999) Effects of volatile anesthetics on the activity of laryngeal drive receptors in anesthetized dogs. J Vet Med Sci 61:1033–1038

    CAS  Article  PubMed  Google Scholar 

  27. Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical overview. CMAJ 172:1703–1711

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hodges MR, Tattersall GJ, Harris MB et al (2008) Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons. J Neurosci 28:2495–2505

    CAS  Article  PubMed  Google Scholar 

  29. Kanamaru M, Homma I (2007) Compensatory airway dilation and additive ventilatory augmentation mediated by dorsomedial medullary 5-hydroxytryptamine 2 receptor activity and hypercapnia. Am J Physiol Regul Integr Comp Physiol 293:R854–R860

    CAS  Article  PubMed  Google Scholar 

  30. Xu H, Guan J, Yi H, Yin S (2014) A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome. PLoS One 9(1):e86460

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yalciner G, Babademez MA, Gul F (2017) Association of sleep time in supine position with apnea-hypopnea index as evidenced by successive polysomnography. Sleep Breath 21(2):289–294

    Article  PubMed  Google Scholar 

  32. Ahmadi N, Shapiro GK, Chung SA, Shapiro CM (2009) Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography. Sleep Breath 13:221–226

    Article  PubMed  Google Scholar 

  33. Stepnowsky CJ Jr, Orr WC, Davidson TM (2004) Nightly variability of sleep-disordered breathing measured over 3 nights. Otolaryngol Head Neck Surg 131:837–843

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Rasoul Ghadami.

Ethics declarations

Funding

No funding was received for this research.

Ethical approval

All procedures performed in this study was approved by the ethics board of Kermanshah Medical University (KUMS) in Kermanshah, Iran.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare that they do not have any financial conflict of interest related to the topic of the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Khazaie, H., Sharafkhaneh, A., Khazaie, S. et al. A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea. Sleep Breath 22, 109–114 (2018). https://doi.org/10.1007/s11325-017-1537-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-017-1537-y

Keywords

  • Atypical antipsychotic
  • Obstructive sleep apnea
  • Weight gain
  • Polysomnography